U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187021187021Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRecruitingNo Results AvailableChronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Stage III Chronic Lymphocytic Leukemia|Stage III Small Lymphocytic Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV SmDrug: Fludarabine Phosphate|Biological: Rituximab|Radiation: Total-Body Irradiation|Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Peripheral Blood Stem Cell Transplantation|Drug: Cyclosporine|Drug: Mycophenolate Mofetil|Other: Laboratory Biomarker Analysis|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT00104858
187022187022Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: human gp100 plasmid DNA vaccine|Biological: mouse gp100 plasmid DNA vaccinehttps://ClinicalTrials.gov/show/NCT00104845
187023187023Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's LymphomaTerminatedNo Results AvailableLymphomaBiological: autologous immunoglobulin idiotype-KLH conjugate vaccine|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00104819
187024187024Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic SyndromesTerminatedNo Results AvailableLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsDietary Supplement: cholecalciferol|Drug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00104806
187025187025Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00104793
187026187026Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableLung CancerBiological: EP-2101|Biological: incomplete Freund's adjuvanthttps://ClinicalTrials.gov/show/NCT00104780
187027187027Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableLung CancerDrug: celecoxibhttps://ClinicalTrials.gov/show/NCT00104767
187028187028Liposomal SN-38 in Treating Patients With Small Cell Lung CancerWithdrawnNo Results AvailableLung CancerDrug: liposomal SN-38https://ClinicalTrials.gov/show/NCT00104754
187029187029Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerRecruitingNo Results AvailableProstate CancerDrug: flutamide|Drug: triptorelin|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00104741
187030187030Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular CorrelatesTerminatedHas ResultsLung CancerDrug: ZD1839https://ClinicalTrials.gov/show/NCT00104728
187031187031Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: antiandrogen therapy|Drug: docetaxel|Drug: goserelin acetate|Procedure: orchiectomyhttps://ClinicalTrials.gov/show/NCT00104715
187032187032Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast CancerCompletedNo Results AvailableBreast CancerProcedure: adjuvant therapy|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00104702
187033187033Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerActive, not recruitingNo Results AvailableColorectal CancerDrug: capecitabine|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00104689
187034187034Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell TumorsRecruitingNo Results AvailableExtragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell TumorBiological: bleomycin sulfate|Drug: cisplatin|Drug: etoposide|Drug: ifosfamide|Drug: oxaliplatin|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00104676
187035187035PRION-1: Quinacrine for Human Prion DiseaseCompletedNo Results AvailablePrion DiseaseDrug: Quinacrinehttps://ClinicalTrials.gov/show/NCT00104663
187036187036Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesCompletedHas ResultsBone Metastases in Men With Hormone-Refractory Prostate Cancer|Bone Metastases in Subjects With Advanced Breast Cancer|Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaGenetic: AMG 162 180 mg (SC) q 12 weeks|Drug: IV Bisphosphonate q 4 weeks|Genetic: AMG 162- 180 mg q 4 weekshttps://ClinicalTrials.gov/show/NCT00104650
187037187037Sildenafil for Chronic Obstructive Pulmonary DiseaseCompletedHas ResultsPulmonary Disease, Chronic Obstructive|EmphysemaDrug: sildenafil citrate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00104637
187038187038Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNo Results AvailableBreast CancerDrug: docetaxel|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00104624
187039187039Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDevice: Repetitive Transcranial Magnetic Stimulationhttps://ClinicalTrials.gov/show/NCT00104611
187040187040Framing Messages for Smoking Cessation With Bupropion - 6CompletedNo Results AvailableTobacco Use DisorderDrug: Bupropion|Behavioral: Smoking Abstinence Programhttps://ClinicalTrials.gov/show/NCT00104598
187041187041Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)RecruitingNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00104585
187042187042The Effects of Aromatase Inhibition and Testosterone Replacement on Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older MenCompletedNo Results AvailableHypogonadism|Diabetes|Sarcopenia|Osteoporosis|CognitionDrug: Androgel (Testosterone Gel)|Drug: Anastrozole (Aromatase Inhibitor)|Drug: Placebo tablet|Drug: Placebo gel|Dietary Supplement: Calcium Cardone 500mg with vitamin D 400 IUhttps://ClinicalTrials.gov/show/NCT00104572
187043187043Computer-Generated Vs. Standard Informed Consent for HIV Research StudiesActive, not recruitingNo Results AvailableHIV InfectionsBehavioral: iMIC-generated consent form and tutorial|Behavioral: Standard paper consent formhttps://ClinicalTrials.gov/show/NCT00104559
187044187044Vitamin K Injections for the Treatment of Painful MenstruationCompletedNo Results AvailableDysmenorrheaProcedure: Acupuncture point injection of vitamin Khttps://ClinicalTrials.gov/show/NCT00104546
187045187045Effectiveness of Magnetic Therapy on Pain IntensityCompletedNo Results AvailablePostoperative PainDevice: Magnetshttps://ClinicalTrials.gov/show/NCT00104533
187046187046Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedHas ResultsCystic FibrosisDrug: AZLI 75 mg two times a day (BID)/three times a day (TID)|Drug: Placebo two times a day (BID)/three times a day (TID)https://ClinicalTrials.gov/show/NCT00104520
187047187047Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNo Results AvailableObesityDrug: APD356https://ClinicalTrials.gov/show/NCT00104507
187048187048Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)CompletedNo Results AvailableCystic FibrosisDrug: Zinc acetate (20mg/d)https://ClinicalTrials.gov/show/NCT00104494
187049187049Group Counseling for Smoking CessationCompletedNo Results AvailableSmokingBehavioral: cognitive behavior therapyhttps://ClinicalTrials.gov/show/NCT00104481
187050187050Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)TerminatedNo Results AvailableAcute Myelogenous LeukemiaDrug: Troxatylâ„¢ (Cytotoxic Chemotherapeutic)https://ClinicalTrials.gov/show/NCT00104468

* Görseller ve İçerik tekif hakkına sahip olabilir